The study for determining the drug resposible for perioperative anaphylaxis by using skin test and flow cytometry

The study for determining the drug resposible for perioperative anaphylaxis by using skin test and flow cytometry - The study for determining the drug resposible for perioperative anaphylaxis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015751

Enrollment

Registered

2014-11-25

Start date

2014-04-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anaphylaxis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patient 13 years or older, who underwent general or spinal anesthesia 2) The patient with perioperative anaphylaxis 3) The patient whose consent has been obtained in writing with respect to participation in this study

Exclusion criteria

Exclusion criteria: 1)The pregnant woman /The patient who has a possibility of pregnancy 2)The patient taking beta blocker 3)The patient taking steroid 4)The patient to whom a doctor judged inappropriate for participating in this study

Design outcomes

Primary

Measure	Time frame
Identifying the drug responsible for perioperative anaphylaxis	—

Countries

Japan

Contacts

Public ContactTomonori TAKAZAWA

Gunma University Hospital Department of Anesthesiology

takazawt@gunma-u.ac.jp027-220-8454

Outcome results